Matches in SemOpenAlex for { <https://semopenalex.org/work/W936667257> ?p ?o ?g. }
Showing items 1 to 97 of
97
with 100 items per page.
- W936667257 endingPage "42" @default.
- W936667257 startingPage "31" @default.
- W936667257 abstract "Antidepressant and antipsychotic drugs, predominantly serotonin and/or norepinephrine reuptake inhibitors and dopamine D2-antagonizing antipsychotic compounds, have several limitations. In addition, the exact pathophysiological mechanism leading to serotonergic, noradrenergic and dopaminergic dysfunction in psychotic disorders remains unclear. It has been postulated that an inflammatory mechanism may be involved in the pathogenesis of both depression and psychotic disorders. Furthermore, the differential activation of the enzyme indoleamine 2,3-dioxygenase (IDO) and of the tryptophan/kynurenine metabolic pathway, resulting in the increased production of kynurenic acid in schizophrenia, and a possible increase in quinolinic acid in depression, also may play a key role in these diseases. Such differences are associated with an imbalance in glutamatergic neurotransmission that may contribute to increased levels of NMDA agonism in depression and NMDA antagonism in schizophrenia. In addition, immunological imbalance results in the increased production of PGE2 in schizophrenia and depression, as well as increased COX-2 expression in schizophrenia. Although there is evidence supporting the hypothesis that interactions between immune system components, IDO, the serotonergic system and glutamatergic neurotransmission play a key role in schizophrenia and depression, several gaps in knowledge remain, such as regarding the role of genetics, disease course, gender and different psychopathological states. There is evidence indicating that anti-inflammatory therapy may have beneficial effects in schizophrenia and major depression (MD). COX-2 inhibitors have been tested in animal models and in preliminary clinical trials, demonstrating favorable activity compared with placebo, both in schizophrenia and MD. However, the effects of COX-2 inhibition in the CNS, as well as toward different components of the inflammatory system, kynurenine metabolism and glutamatergic neurotransmission, require further evaluation, which should include clinical trials with larger numbers of patients. The potential inflammatory mechanism in schizophrenia and MD, and the possible therapeutic advantages of targeting this mechanism in the treatment of these disorders is discussed in this review." @default.
- W936667257 created "2016-06-24" @default.
- W936667257 creator A5021100257 @default.
- W936667257 date "2010-01-01" @default.
- W936667257 modified "2023-09-29" @default.
- W936667257 title "COX-2 inhibitors as antidepressants and antipsychotics: clinical evidence." @default.
- W936667257 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20047157" @default.
- W936667257 hasPublicationYear "2010" @default.
- W936667257 type Work @default.
- W936667257 sameAs 936667257 @default.
- W936667257 citedByCount "38" @default.
- W936667257 countsByYear W9366672572012 @default.
- W936667257 countsByYear W9366672572013 @default.
- W936667257 countsByYear W9366672572014 @default.
- W936667257 countsByYear W9366672572015 @default.
- W936667257 countsByYear W9366672572016 @default.
- W936667257 countsByYear W9366672572017 @default.
- W936667257 countsByYear W9366672572018 @default.
- W936667257 countsByYear W9366672572019 @default.
- W936667257 countsByYear W9366672572020 @default.
- W936667257 countsByYear W9366672572021 @default.
- W936667257 countsByYear W9366672572022 @default.
- W936667257 crossrefType "journal-article" @default.
- W936667257 hasAuthorship W936667257A5021100257 @default.
- W936667257 hasConcept C118552586 @default.
- W936667257 hasConcept C126322002 @default.
- W936667257 hasConcept C137183658 @default.
- W936667257 hasConcept C15744967 @default.
- W936667257 hasConcept C169760540 @default.
- W936667257 hasConcept C170493617 @default.
- W936667257 hasConcept C25876315 @default.
- W936667257 hasConcept C2775864247 @default.
- W936667257 hasConcept C2775870346 @default.
- W936667257 hasConcept C2776412080 @default.
- W936667257 hasConcept C2776841986 @default.
- W936667257 hasConcept C2776921671 @default.
- W936667257 hasConcept C2779177272 @default.
- W936667257 hasConcept C2779727114 @default.
- W936667257 hasConcept C2780494398 @default.
- W936667257 hasConcept C37000724 @default.
- W936667257 hasConcept C513476851 @default.
- W936667257 hasConcept C558461103 @default.
- W936667257 hasConcept C67018056 @default.
- W936667257 hasConcept C71924100 @default.
- W936667257 hasConcept C98274493 @default.
- W936667257 hasConceptScore W936667257C118552586 @default.
- W936667257 hasConceptScore W936667257C126322002 @default.
- W936667257 hasConceptScore W936667257C137183658 @default.
- W936667257 hasConceptScore W936667257C15744967 @default.
- W936667257 hasConceptScore W936667257C169760540 @default.
- W936667257 hasConceptScore W936667257C170493617 @default.
- W936667257 hasConceptScore W936667257C25876315 @default.
- W936667257 hasConceptScore W936667257C2775864247 @default.
- W936667257 hasConceptScore W936667257C2775870346 @default.
- W936667257 hasConceptScore W936667257C2776412080 @default.
- W936667257 hasConceptScore W936667257C2776841986 @default.
- W936667257 hasConceptScore W936667257C2776921671 @default.
- W936667257 hasConceptScore W936667257C2779177272 @default.
- W936667257 hasConceptScore W936667257C2779727114 @default.
- W936667257 hasConceptScore W936667257C2780494398 @default.
- W936667257 hasConceptScore W936667257C37000724 @default.
- W936667257 hasConceptScore W936667257C513476851 @default.
- W936667257 hasConceptScore W936667257C558461103 @default.
- W936667257 hasConceptScore W936667257C67018056 @default.
- W936667257 hasConceptScore W936667257C71924100 @default.
- W936667257 hasConceptScore W936667257C98274493 @default.
- W936667257 hasIssue "1" @default.
- W936667257 hasLocation W9366672571 @default.
- W936667257 hasOpenAccess W936667257 @default.
- W936667257 hasPrimaryLocation W9366672571 @default.
- W936667257 hasRelatedWork W1555366957 @default.
- W936667257 hasRelatedWork W1976582031 @default.
- W936667257 hasRelatedWork W1980302503 @default.
- W936667257 hasRelatedWork W1985438873 @default.
- W936667257 hasRelatedWork W1996454121 @default.
- W936667257 hasRelatedWork W2024908874 @default.
- W936667257 hasRelatedWork W2030396834 @default.
- W936667257 hasRelatedWork W2030765669 @default.
- W936667257 hasRelatedWork W2036194983 @default.
- W936667257 hasRelatedWork W2042755650 @default.
- W936667257 hasRelatedWork W2049808835 @default.
- W936667257 hasRelatedWork W2082535880 @default.
- W936667257 hasRelatedWork W2084588595 @default.
- W936667257 hasRelatedWork W2091259554 @default.
- W936667257 hasRelatedWork W2097740790 @default.
- W936667257 hasRelatedWork W2102204071 @default.
- W936667257 hasRelatedWork W2126795224 @default.
- W936667257 hasRelatedWork W2159428631 @default.
- W936667257 hasRelatedWork W2170561948 @default.
- W936667257 hasRelatedWork W2171149822 @default.
- W936667257 hasVolume "11" @default.
- W936667257 isParatext "false" @default.
- W936667257 isRetracted "false" @default.
- W936667257 magId "936667257" @default.
- W936667257 workType "article" @default.